Kong Yek-Ching, Bhoo-Pathy Nirmala, Subramaniam Shridevi, Bhoo-Pathy Nanthini, Taib Nur Aishah, Jamaris Suniza, Kaur Kiran, See Mee-Hoong, Ho Gwo-Fuang, Yip Cheng-Har
National Clinical Research Centre, Ministry of Health, Kuala Lumpur 50586, Malaysia.
Department of Social and Preventive Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Int J Environ Res Public Health. 2017 Apr 16;14(4):427. doi: 10.3390/ijerph14040427.
Survival disparities in cancer are known to occur between public and private hospitals. We compared breast cancer presentation, treatment and survival between a public academic hospital and a private hospital in a middle-income country. The demographics, clinical characteristics, treatment and overall survival (OS) of 2767 patients with invasive breast carcinoma diagnosed between 2001 and 2011 in the public hospital were compared with 1199 patients from the private hospital. Compared to patients in the private hospital, patients from the public hospital were older at presentation, and had more advanced cancer stages. They were also more likely to receive mastectomy and chemotherapy but less radiotherapy. The five-year OS in public patients was significantly lower than in private patients (71.6% vs. 86.8%). This difference was largely attributed to discrepancies in stage at diagnosis and, although to a much smaller extent, to demographic differences and treatment disparities. Even following adjustment for these factors, patients in the public hospital remained at increased risk of mortality compared to their counterparts in the private hospital (Hazard Ratio: 1.59; 95% Confidence Interval: 1.36-1.85). Late stage at diagnosis appears to be a major contributing factor explaining the breast cancer survival disparity between public and private patients in this middle-income setting.
众所周知,公立医院和私立医院在癌症患者生存率方面存在差异。我们比较了一个中等收入国家的一家公立学术医院和一家私立医院中乳腺癌患者的就诊情况、治疗情况及生存率。将2001年至2011年期间在公立医院确诊的2767例浸润性乳腺癌患者的人口统计学特征、临床特征、治疗情况及总生存率(OS)与私立医院的1199例患者进行了比较。与私立医院的患者相比,公立医院的患者就诊时年龄更大,癌症分期更晚。他们接受乳房切除术和化疗的可能性也更大,但接受放疗的可能性更小。公立医院患者的五年总生存率显著低于私立医院患者(71.6%对86.8%)。这种差异在很大程度上归因于诊断时分期的差异,尽管程度小得多,也归因于人口统计学差异和治疗差异。即使对这些因素进行调整后,公立医院的患者与私立医院的患者相比,死亡风险仍然更高(风险比:1.59;95%置信区间:1.36 - 1.85)。在这种中等收入环境下,诊断时的晚期似乎是解释公立和私立患者乳腺癌生存差异的一个主要因素。